Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

Drug firms seek new cash sources

Article Abstract:

The pharmaceutical industry is seeking greater financing to produce big selling drugs. As an alternative the giant industry has a great amount of working capital that could be channelled into financing new ventures, reducing debts or paying dividends.

Author: Jones, Steven D.
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2005
United States, Forecasts, trends, outlooks, Financial management, Pharmaceutical preparations, Industry Overview, Economic aspects, Company financing, Industry forecasts

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Schering's net rose 18% for the quarter, but sales may slow

Article Abstract:

Schering AG posted a rise of 18% in its net for the 2002 fourth quarter. However, the company may see slower sales in 2003. Schering posted 103 million euros in net for the quarter.

Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
Germany, Sales, profits & dividends, Company sales and earnings, Company earnings/profit, Schering AG

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: Pharmaceutical industry, Finance
Similar abstracts:
  • Abstracts: Blueprint for urban villages. Catering for the disabled
  • Abstracts: Heralding a new renaissance. Privatising in St Petersburg. Architect of choice
  • Abstracts: Business as the new rock and roll. The kingdom inside a republic. Waiting for Dumbo: Euro Disney
  • Abstracts: To phrase a coin. Shooting the messengers: the market. Europe's future: in their hands?
  • Abstracts: Asean faces new challenges. Resolving Asean's problems
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.